Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus esketamine dosing for extubation cough and recovery after thyroid surgery
ChiCTR2400090449Phase 4Completed
- Sponsor
- Guizhou Provincial People's Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (4 arms), sponsored by Guizhou Provincial People's Hospital. Primary endpoints: Minogue score and Numerical Rating Scale (NRS) pain score. Started Sep 2024; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2400090449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090449.